Variant report
Variant | nsv514216 |
---|---|
Chromosome Location | chr4:59980425-59988085 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74748663 | chr4:59985046-59985047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574269418 | chr4:59985052-59985053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541951473 | chr4:59985072-59985073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs357838 | chr4:59985093-59985094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs530830214 | chr4:59985098-59985099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111864318 | chr4:59985110-59985111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533941356 | chr4:59985151-59985152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6852453 | chr4:59985190-59985191 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs547311271 | chr4:59985221-59985222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187085089 | chr4:59985222-59985223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115592905 | chr4:59985227-59985228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573637146 | chr4:59985238-59985239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77684225 | chr4:59985331-59985332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74588556 | chr4:59985387-59985388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs66541102 | chr4:59985388-59985389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191605904 | chr4:59985389-59985390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111508132 | chr4:59985392-59985393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184512408 | chr4:59985494-59985495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536651273 | chr4:59985516-59985517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556669051 | chr4:59985540-59985541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368748687 | chr4:59985542-59985543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534628739 | chr4:59985549-59985550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141251192 | chr4:59985589-59985590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552830502 | chr4:59985632-59985633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574305619 | chr4:59985650-59985651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112650796 | chr4:59985717-59985718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145377153 | chr4:59985727-59985728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563637404 | chr4:59985753-59985754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188983193 | chr4:59985770-59985771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545974289 | chr4:59985780-59985781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs137934273 | chr4:59985797-59985798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79397085 | chr4:59985878-59985879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547352231 | chr4:59985884-59985885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562335478 | chr4:59985898-59985899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542405256 | chr4:59985946-59985947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78089784 | chr4:59985951-59985952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182471894 | chr4:59985995-59985996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530676142 | chr4:59986003-59986004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551962838 | chr4:59986056-59986057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113739033 | chr4:59986062-59986063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570460268 | chr4:59986077-59986078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539888940 | chr4:59986097-59986098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564882946 | chr4:59986116-59986117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567498327 | chr4:59986125-59986126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142393903 | chr4:59986129-59986130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552867925 | chr4:59986172-59986173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567964219 | chr4:59986179-59986180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185416937 | chr4:59986191-59986192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115477665 | chr4:59986249-59986250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189062704 | chr4:59986284-59986285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:59985000-59986200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:59985000-59987200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr4:59985400-59987000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr4:59986000-59986400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr4:59986200-59987000 | Enhancers | A549 | lung |
6 | chr4:59986200-59988200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:59986400-59986800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr4:59986400-59987200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr4:59986800-59987000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr4:59986800-59987000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr4:59987000-59988200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
12 | chr4:59987000-59991000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:59987200-59988200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr4:59987200-59990800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |